ACAD
31.08
+0.05
+0.16%
AEMD
1.53
-0.09
-5.56%
APRI
1.49
-0.01
-0.67%
ARNA
20.53
-0.05
-0.24%
ATEC
1.92
+0.08
+4.35%
CNAT
5.01
-0.12
-2.34%
CRXM
0.163
+0.004
+2.51351%
CYTX
0.323
-0.005
-1.5568%
DXCM
73.2
+0.42
+0.58%
GNMK
9.6
-0.09
-0.93%
HALO
11.88
+0.12
+1.02%
ILMN
189.32
-1.88
-0.98%
INNV
0.1
0.00
0.00%
INO
5.45
+0.09
+1.68%
ISCO
1.32
-0.03
-2.22%
ISIS
57.56
0.00
0.00%
LGND
126.26
-0.36
-0.28%
LPTN
2.93
-2.93
-100.00%
MBVX
0.5
+0.02
+4.14%
MEIP
2.68
-0.06
-2.19%
MNOV
4.97
+0.01
+0.20%
MRTX
5.6
+0.55
+10.89%
MSTX
0.13
-0.01
-5.28%
NBIX
52.15
-0.97
-1.83%
NUVA
64.06
-1.87
-2.84%
ONCS
0.92
0.00
0.00%
ONVO
1.85
-0.16
-7.96%
OREX
2.42
-0.02
-0.82%
OTIC
18.75
-0.1
-0.53%
QDEL
32.61
+0.14
+0.43%
RCPT
231.96
0.00
0.00%
RGLS
0.826
-0.044
-5.0460%
RMD
73.07
+0.28
+0.38%
SCIE
0
0.00
0.00%
SPHS
1.9
+0.04
+2.16%
SRNE
1.75
+0.05
+2.94%
TROV
0.83
+0.02
+2.4321%
VICL
2.43
+0.03
+1.25%
VOLC
18
0.00
0.00%
ZGNX
12.25
+0.2
+1.66%
ACAD
31.08
+0.05
+0.16%
AEMD
1.53
-0.09
-5.56%
APRI
1.49
-0.01
-0.67%
ARNA
20.53
-0.05
-0.24%
ATEC
1.92
+0.08
+4.35%
CNAT
5.01
-0.12
-2.34%
CRXM
0.163
+0.004
+2.51351%
CYTX
0.323
-0.005
-1.5568%
DXCM
73.2
+0.42
+0.58%
GNMK
9.6
-0.09
-0.93%
HALO
11.88
+0.12
+1.02%
ILMN
189.32
-1.88
-0.98%
INNV
0.1
0.00
0.00%
INO
5.45
+0.09
+1.68%
ISCO
1.32
-0.03
-2.22%
ISIS
57.56
0.00
0.00%
LGND
126.26
-0.36
-0.28%
LPTN
2.93
-2.93
-100.00%
MBVX
0.5
+0.02
+4.14%
MEIP
2.68
-0.06
-2.19%
MNOV
4.97
+0.01
+0.20%
MRTX
5.6
+0.55
+10.89%
MSTX
0.13
-0.01
-5.28%
NBIX
52.15
-0.97
-1.83%
NUVA
64.06
-1.87
-2.84%
ONCS
0.92
0.00
0.00%
ONVO
1.85
-0.16
-7.96%
OREX
2.42
-0.02
-0.82%
OTIC
18.75
-0.1
-0.53%
QDEL
32.61
+0.14
+0.43%
RCPT
231.96
0.00
0.00%
RGLS
0.826
-0.044
-5.0460%
RMD
73.07
+0.28
+0.38%
SCIE
0
0.00
0.00%
SPHS
1.9
+0.04
+2.16%
SRNE
1.75
+0.05
+2.94%
TROV
0.83
+0.02
+2.4321%
VICL
2.43
+0.03
+1.25%
VOLC
18
0.00
0.00%
ZGNX
12.25
+0.2
+1.66%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …